
aled edwards
@aledmedwards
Followers
3K
Following
27
Media
354
Statuses
6K
Open access science and drug discovery. Founded and (still) direct @thesgconline. My comms folks shudder when I tweet.
Toronto
Joined October 2010
RT @thesgconline: A well anticipated overview highlighting the first CACHE challenge, which brought together 23 research teams from 10 coun….
pubs.acs.org
The CACHE challenges are a series of prospective benchmarking exercises to evaluate progress in the field of computational hit-finding. Here we report the results of the inaugural CACHE challenge in...
0
8
0
RT @thesgconline: A news feature by @Nature addresses the longstanding issue of unreliable antibodies in biomedical research and highlights….
nature.com
Nature - Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
0
3
0
RT @consciencemeds: Save the date for the second annual Conscience Symposium on Open Drug Discovery! Join us in Montreal on April 7-8, 2025….
0
2
0
Want to be a fly on the wall in an industry-standard drug discovery program? Join the M4K Pharma monthly zooms. Real pros at work, sharing their expertise to try to invent an open source medicine to treat children’s brain tumours.
M4K Pharma's October Scientific Update meeting is now available online: .In this session, our team provides detailed insights into the latest progress on developing new treatments for DIPG through our #OpenScience approach. #BrainCancer #Medicines4Kids.
0
0
1
Waiting to board flight to Toronto and just in front of me in line was @FP_Champagne, Canada’s Minister of Industry and other things. He headed to his seat in economy (as did I). Spending Canadian tax dollars wisely. Gotta like it.
2
1
7
RT @open_fold: #AlphaFold3 is open-source for academic use now! See what our partner, @MoAlQuraishi, has to say about our upcoming OpenFold….
nature.com
Nature - The code underlying the Nobel-prize-winning tool for modelling protein structures can now be downloaded by academics.
0
13
0
RT @target2035: Just Launched! Episode 1 of the Target 2035 Podcast Series🎧 In the debut episode, @LabScribbles welcomes @CherylArrowsmi1,….
0
4
0
It’s very encouraging that funders support projects like YCharOS, which does not address hypotheses, but rather does the foundational, but not sexy, work of testing and characterizing reagent antibodies in order to make everyone else’s science more robust and reproducible.
CQDM is proud to announce the funding of a collaborative research project made possible through a grant of nearly Can$1.49M from the Government of Quebec (@economie_quebec). A project of @YCharOS1 in partnership with @mcgillu. 👉
0
1
3
Congrats to @thesgconline Board member, Dafydd Owen 🏴, for leading the team that invented the active ingredient in Paxlovid, which was awarded a #PrixGalien prize last night!.
0
0
4
RT @JonnyRoot_: Steve Kerr on the election. Kerr: “I believe in democracy. I think the American people have spoken and voted for Trump. I w….
0
6K
0
RT @DanielJDrucker: Draining the swamp. Assessment of 614 commercial antibodies, targeting a total of 65 neuroscience-related proteins, dem….
nature.com
Nature - Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
0
8
0
RT @TheNeuro_MNI: Neuroscientist Carl Laflamme describes @YCharOS1, an initiative testing commercial antibodies to determine if they work a….
0
4
0
Does machine learning work on DEL datasets? Indeed it does. Sometimes.
pubs.acs.org
Target class-focused drug discovery has a strong track record in pharmaceutical research, yet public domain data indicate that many members of protein families remain unliganded. Here we present a...
0
1
5